Aqua Bio Technology ASA (ABT.OL)

NOK 6.93

(0.0%)

Total Assets Summary of Aqua Bio Technology ASA

Aqua Bio Technology ASA's latest annual total assets in 2021 was 34.42 Million NOK , up 112.03% from previous year.
Aqua Bio Technology ASA's latest quarterly total assets in 2022 Q2 was 21.08 Million NOK , down 0.0% from previous quarter.
Aqua Bio Technology ASA reported annual total assets of 16.23 Million NOK in 2020, up 56.34% from previous year.
Aqua Bio Technology ASA reported annual total assets of 10.38 Million NOK in 2019, down -65.43% from previous year.
Aqua Bio Technology ASA reported quarterly total assets of 28.93 Million NOK for 2021 Q2, down 0.0% from previous quarter.
Aqua Bio Technology ASA reported quarterly total assets of 34.42 Million NOK for 2021 FY, up 112.03% from previous quarter.

Annual Total Assets Chart of Aqua Bio Technology ASA (2021 - 2008)

Historical Annual Total Assets of Aqua Bio Technology ASA (2021 - 2008)

Year	Total Assets	Total Assets Growth
2021	34.42 Million NOK	112.03%
2020	16.23 Million NOK	56.34%
2019	10.38 Million NOK	-65.43%
2018	30.04 Million NOK	-38.8%
2017	49.08 Million NOK	-31.27%
2016	71.42 Million NOK	-17.02%
2015	86.06 Million NOK	13.61%
2014	75.75 Million NOK	-3.21%
2013	78.26 Million NOK	0.13%
2012	78.16 Million NOK	15.75%
2011	67.53 Million NOK	-2.26%
2010	69.09 Million NOK	-3.82%
2009	71.83 Million NOK	-4.8%
2008	75.45 Million NOK	0.0%

Year	Total Assets	Total Assets Growth
2022 Q2	21.08 Million NOK	0.0%
2021 Q2	28.93 Million NOK	0.0%
2021 FY	34.42 Million NOK	112.03%
2021 Q4	34.42 Million NOK	0.0%
2020 FY	16.23 Million NOK	56.34%
2020 Q4	16.23 Million NOK	0.0%
2020 Q2	4.04 Million NOK	0.0%
2019 Q2	31.87 Million NOK	0.0%
2019 Q4	10.38 Million NOK	0.0%
2019 FY	10.38 Million NOK	-65.43%
2018 Q2	38.75 Million NOK	0.0%
2018 Q4	30.04 Million NOK	0.0%
2018 FY	30.04 Million NOK	-38.8%
2017 Q2	59.56 Million NOK	0.0%
2017 FY	49.08 Million NOK	-31.27%
2017 Q4	49.08 Million NOK	0.0%
2016 Q2	85.71 Million NOK	-6.28%
2016 Q1	91.45 Million NOK	6.26%
2016 Q4	71.42 Million NOK	-2.66%
2016 FY	71.42 Million NOK	-17.02%
2016 Q3	73.37 Million NOK	-14.39%
2015 Q3	78.37 Million NOK	3.2%
2015 FY	86.06 Million NOK	13.61%
2015 Q2	75.94 Million NOK	-3.2%
2015 Q1	78.45 Million NOK	3.57%
2015 Q4	86.06 Million NOK	9.82%
2014 FY	75.75 Million NOK	-3.21%
2014 Q4	75.75 Million NOK	1.11%
2014 Q3	74.92 Million NOK	-2.0%
2014 Q2	76.45 Million NOK	-0.57%
2014 Q1	76.9 Million NOK	-1.75%
2013 Q3	78.55 Million NOK	-1.38%
2013 FY	78.26 Million NOK	0.13%
2013 Q4	78.26 Million NOK	-0.36%
2013 Q1	77.05 Million NOK	-1.42%
2013 Q2	79.65 Million NOK	3.36%
2012 FY	78.16 Million NOK	15.75%
2012 Q4	78.16 Million NOK	4.44%
2012 Q3	74.84 Million NOK	-0.85%
2012 Q2	75.48 Million NOK	0.36%
2012 Q1	75.21 Million NOK	11.38%
2011 FY	67.53 Million NOK	-2.26%
2011 Q2	67.19 Million NOK	-4.18%
2011 Q4	67.53 Million NOK	5.58%
2011 Q3	63.96 Million NOK	-4.82%
2011 Q1	70.12 Million NOK	1.5%
2010 FY	69.09 Million NOK	-3.82%
2010 Q4	69.09 Million NOK	0.0%
2009 FY	71.83 Million NOK	-4.8%
2008 FY	75.45 Million NOK	0.0%

Peer Total Assets Comparison of Aqua Bio Technology ASA

Name	Total Assets	Total Assets Difference
Arctic Bioscience AS	300.25 Million NOK	88.533%
ArcticZymes Technologies ASA	339.32 Million NOK	89.853%
BerGenBio ASA	174.33 Million NOK	80.251%
Hofseth BioCare ASA	390.11 Million NOK	91.175%
PCI Biotech Holding ASA	44.05 Million NOK	21.84%
Thor Medical ASA	330.83 Million NOK	89.593%
Ultimovacs ASA	349.03 Million NOK	90.136%